
How AI is Transforming the Biopharmaceutical Value Chain
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, “How AI is Transforming the Biopharmaceutical Value Chain from Discovery to

Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, “How AI is Transforming the Biopharmaceutical Value Chain from Discovery to

The international success of GLP-1 agonists for weight loss is overwhelming pharma safety operations as they strive to monitor incoming adverse events, says Daniel O’keeffe
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she outlines how proactive PV, translational safety, AI foundations, and
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she explains how AI could revolutionize pharmacovigilance, if data, trust,
Qinecsa Chief Product Officer, Beena Wood, has been featured in Pharm Tech’s latest issue, where she saw 2025 as an AI superposition in which pharmacovigilence
Qinecsa Chief Operating Officer, John Cogan, has been featured in The Pharma Navigator latest issue, where he discusses trends from 2025 for the bio/pharma industry.
Qinecsa VP, Product Management Reportum, Daniel O’Keeffe, has been featured in PharmaTimes Magazine latest issue, where he discusses how AI alone won’t solve pharma’s fragmented

Qinecsa Chief Operating Officer, John Cogan, has been featured in International Pharmaceutical Industry latest issue, where he predicts industry trends for the year ahead and

Applying artificial intelligence (AI) to fragmented and incomplete safety data cannot fill the gap left when the right information has not been captured during initial

Qinecsa Chief Operating Officer, John Cogan, has been featured in Bio IT World latest issue, where he predicts trends in artificial intelligence, impact of global